EE03105B1 - Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess - Google Patents

Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess

Info

Publication number
EE03105B1
EE03105B1 EE9400416A EE9400416A EE03105B1 EE 03105 B1 EE03105 B1 EE 03105B1 EE 9400416 A EE9400416 A EE 9400416A EE 9400416 A EE9400416 A EE 9400416A EE 03105 B1 EE03105 B1 EE 03105B1
Authority
EE
Estonia
Prior art keywords
preparation
pharmacologically
active ingredient
formulations containing
ionizable active
Prior art date
Application number
EE9400416A
Other languages
English (en)
Estonian (et)
Inventor
Lindstedt Bengt
Johan Lundberg Per
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE03105B1 publication Critical patent/EE03105B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
EE9400416A 1990-12-07 1994-11-17 Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess EE03105B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (1)

Publication Number Publication Date
EE03105B1 true EE03105B1 (et) 1998-08-17

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400416A EE03105B1 (et) 1990-12-07 1994-11-17 Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess

Country Status (17)

Country Link
US (2) US5707656A (hu)
EP (1) EP0560816B1 (hu)
JP (1) JP3276956B2 (hu)
AT (1) ATE444737T1 (hu)
AU (1) AU656346B2 (hu)
CA (1) CA2097176C (hu)
DE (1) DE69133623D1 (hu)
EE (1) EE03105B1 (hu)
FI (1) FI932553A0 (hu)
HU (1) HU218661B (hu)
IE (1) IE914136A1 (hu)
IS (1) IS1749B (hu)
NO (1) NO305536B1 (hu)
PT (1) PT99720B (hu)
SE (1) SE9003903D0 (hu)
WO (1) WO1992010171A1 (hu)
YU (1) YU186791A (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT946145E (pt) * 1996-12-20 2008-10-17 Mcneil Ppc Inc Fármacos antitússicos libertados por resinas de troca iónica
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
CA2379987A1 (en) * 1999-07-29 2001-02-08 Roxane Laboratories, Inc. Opioid sustained-released formulation
BR0205721A (pt) * 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Formulações de oximorfona de liberação controlada
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
WO2003086353A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
US20090214625A1 (en) * 2005-07-15 2009-08-27 Mizuo Nakayama Drug delivery patch
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
US20100016781A1 (en) * 2005-08-29 2010-01-21 Mizuo Nakayama Iontophoresis device selecting drug to be administered on the basis of information form sensor
NZ566628A (en) * 2005-09-16 2010-02-26 Tti Ellebeau Inc Catheter type iontophoresis apparatus using alternating layers of electrolytes and ion exchange membranes
WO2007038028A1 (en) * 2005-09-28 2007-04-05 Tti Ellebeau, Inc. Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
JP2009509691A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面に多数の活性物質を送達するためのイオントフォレーシス装置
WO2007037476A1 (ja) * 2005-09-30 2007-04-05 Tti Ellebeau, Inc. 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
WO2008087803A1 (ja) * 2007-01-16 2008-07-24 Hokkaido University 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
AR073575A1 (es) * 2008-09-10 2010-11-17 Transcu Ltd Aparato y metodo para dispensar basados en hpc liquidos viscosos en sustratos porosos por ejemplo proceso continuo basado en bandas
US9238078B2 (en) 2009-04-03 2016-01-19 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
WO1992010171A1 (en) 1992-06-25
IE914136A1 (en) 1992-06-17
PT99720B (pt) 2002-04-29
FI932553A (fi) 1993-06-04
HUT64213A (en) 1993-12-28
US5707656A (en) 1998-01-13
JPH06503311A (ja) 1994-04-14
NO932053D0 (no) 1993-06-04
AU656346B2 (en) 1995-02-02
IS3787A7 (is) 1992-06-08
EP0560816A1 (en) 1993-09-22
DE69133623D1 (de) 2009-11-19
EP0560816B1 (en) 2009-10-07
PT99720A (pt) 1992-10-30
HU9301671D0 (en) 1993-09-28
CA2097176C (en) 2002-03-26
HU218661B (hu) 2000-10-28
US5709882A (en) 1998-01-20
NO932053L (no) 1993-07-20
AU8930591A (en) 1992-07-08
SE9003903D0 (sv) 1990-12-07
NO305536B1 (no) 1999-06-21
JP3276956B2 (ja) 2002-04-22
ATE444737T1 (de) 2009-10-15
IS1749B (is) 2000-07-11
YU186791A (sh) 1994-04-05
CA2097176A1 (en) 1992-06-08
FI932553A0 (fi) 1993-06-04

Similar Documents

Publication Publication Date Title
EE03105B1 (et) Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
ATE95983T1 (de) Graduelle verabreichungsstrukturen fuer kaugummi.
ATE22535T1 (de) Pharmazeutische zusammensetzungen fuer die kontinuierliche freigabe des wirkstoffes.
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES2173858T3 (es) Analogos de huperzina a.
DK0727996T3 (da) Fendazolformuleringer
ATE68686T1 (de) System zum freigeben von stoffen in der vagina.
ATE42202T1 (de) Therapeutische zubereitung mit ammoniumnitrat als wirkstoff.
ATE254851T1 (de) Iod-herstellungszusammensetzung
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
DE3862017D1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
ES2013342A6 (es) Procedimiento para preparar composiciones farmaceuticas a base de ingredientes seleccionados principalmente entre alcohol, fenol, polvo de cantarida, yodo y fosforo.
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
SE9902742D0 (sv) New pharmaceutical formultion
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
HUT41962A (en) Insecticides containing as active substance derivatives of piretroid
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

MM4A Lapsed by not paying the annual fees

Effective date: 20021117